Rohman, PJ;
Scott, E;
Richfield, L;
Ramaswami, U;
Hughes, DA;
(2016)
Pregnancies and associated events in women receiving Enzyme Replacement Therapy for late onset Glycogen Storage Disease Type II (Pompe disease).
Journal of Obstetrics and Gynaecology Research
, 42
(10)
pp. 1263-1271.
10.1111/jog.13055.
Preview |
Text
s1-ln23038474-1892865932-1939656818Hwf-1825778054IdV-127645104823038474PDF_HI0001.pdf - Accepted Version Download (620kB) | Preview |
Abstract
AIM: Glycogen storage disease type II (GSD II or Pompe disease; OMIM; 232 300) is a rare autosomal recessive lysosomal storage disorder resulting from deficiency of α-glucosidase and accumulation of glycogen in muscle. Clinical symptoms include weakness of skeletal and respiratory muscles and, in infants, cardiomyopathy. Patients with GSD II receive infusions of recombinant α-glucosidase (enzyme replacement therapy; ERT), which slow the progression of the disease. ERT is given to male and female patients of all ages but as yet little is documented on the effects of continuing ERT during pregnancy. The aim of this case series was therefore to ascertain the pregnancy outcomes of women with GSD II on ERT and to describe adverse events associated with pregnancy, delivery and therapy. METHODS: The medical records of eight women attending the Royal Free Hospital Lysosomal Storage Disorders Unit were reviewed. Four of the eight women had seven pregnancies over a period of 8 years. RESULTS: In this series GSD II was associated with interventional deliveries but normal neonates. Cessation of ERT in early pregnancy resulted in deterioration of maternal symptoms and emergence of allergic reactions on restarting ERT. CONCLUSION: Individualized care plans are required to ensure the best neonatal and maternal outcomes. Consideration should be given to the potential benefits to mother and fetus of continuing ERT during pregnancy.
| Type: | Article |
|---|---|
| Title: | Pregnancies and associated events in women receiving Enzyme Replacement Therapy for late onset Glycogen Storage Disease Type II (Pompe disease) |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/jog.13055 |
| Publisher version: | http://dx.doi.org/10.1111/jog.13055 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript/version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Glycogen storage disease type II; infusion reaction; pregnancy; recombinant α-glucosidase enzyme replacement therapy |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1485775 |
Archive Staff Only
 |
View Item |
